| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/24/2012 | US8163507 Process for the determination of inflammatory processes and pharmaceutical compositions for the treatment thereof |
| 04/24/2012 | US8163506 Use of toll-like receptor-expressing cells |
| 04/24/2012 | US8163505 Methods using PBK1 for identifying agents that treat metabolic disorders |
| 04/24/2012 | US8163504 Combination of sPLA2 activity and OxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event |
| 04/24/2012 | US8163503 Methods of identifying compounds that bind TANGO509 |
| 04/24/2012 | US8163502 Method for predicting the risk of disease based on lectin binding |
| 04/24/2012 | US8163501 Methods of assessing Crohn's disease patient phenotype by I2 serologic response |
| 04/24/2012 | US8163500 Polypeptides and methods for the specific detection of antibodies in patients with a Borrelia infection |
| 04/24/2012 | US8163499 Drug selection for breast cancer therapy using antibody-based arrays |
| 04/24/2012 | US8163498 Method for determination of molecular weight of hyaluronic acid |
| 04/24/2012 | US8163497 Anti-extended type I glycosphingolipid antibody, derivatives thereof and use |
| 04/24/2012 | US8163496 Methods and kits for measuring von Willebrand factor |
| 04/24/2012 | US8163495 Method for isolating and/or identifying mesenchymal stem cells (MSC) |
| 04/24/2012 | US8163494 Method for assessing metastatic properties of breast cancer |
| 04/24/2012 | US8163492 Microfluidic device and methods of using same |
| 04/24/2012 | US8163485 Differential enzymatic fragmentation |
| 04/24/2012 | US8163476 CUDR as biomarker for cancer progression and therapeutic response |
| 04/24/2012 | US8163475 Methods for diagnosis and prognosis of psychotic disorders |
| 04/24/2012 | US8163474 NS1-NP diagnostics of influenza virus infection |
| 04/24/2012 | US8163280 Antibodies to c-Met |
| 04/24/2012 | US8163253 Method for collecting, storing, transporting and assaying a specimen |
| 04/24/2012 | US8163240 Detection device and system |
| 04/24/2012 | US8163238 Automated micro-well plate handling device |
| 04/24/2012 | US8163184 Apparatus and method for separating and concentrating fluids containing multiple components |
| 04/24/2012 | US8163164 Small volume in vitro analyte sensor and methods of making |
| 04/24/2012 | US8163160 Biosensor having improved hematocrit and oxygen biases |
| 04/24/2012 | US8163151 Assays for detection of Von Willebrand factor (vWF) multimers and for degradation of vWF by agents such as Adamts13 and related methods |
| 04/24/2012 | US8163149 Gas-monitoring assembly comprising one or more gas sensors and one or more getters, and method of using same |
| 04/24/2012 | US8163147 Subsystems and methods for use in patch clamp systems |
| 04/24/2012 | US8162853 Tissue penetration device |
| 04/24/2012 | US8161799 Apparatus and methods for evaluation of energetic materials |
| 04/24/2012 | US8161793 Mouth alcohol tester |
| 04/24/2012 | CA2690165C Method for the production of a microfluidic system on a polymer surface |
| 04/24/2012 | CA2688305C Method for the production of an analytical element |
| 04/24/2012 | CA2627593C Dopaminergic neuron proliferative progenitor cell marker nato3 |
| 04/24/2012 | CA2604056C Biological indicator |
| 04/24/2012 | CA2499776C Method and article for applying and monitoring a surfactant |
| 04/24/2012 | CA2499496C Synthesis and characterization of novel systems for guidance and vectorization of compounds having a therapeutic activity |
| 04/24/2012 | CA2411076C A method for the non-invasive measurement of properties of meat |
| 04/19/2012 | WO2012051612A2 System for monitoring underwater characteristics |
| 04/19/2012 | WO2012051519A2 Biomarkers of brain injury |
| 04/19/2012 | WO2012051516A1 Biomarker and method for detecting a chronic inflammatory-asscociated disease |
| 04/19/2012 | WO2012051498A2 Antibodies that bind amyloid oligomers |
| 04/19/2012 | WO2012051463A2 Urine metabolomic profile of diabetic kidney disease |
| 04/19/2012 | WO2012051462A2 Complement factor h copy number variants found in the rca locus |
| 04/19/2012 | WO2012051437A1 Compositions and assays for determining cell viability |
| 04/19/2012 | WO2012051390A1 Methods and kits for the detection of circulating tumor cells in pancreatic patients using polyspecific capture and cocktail detection reagents |
| 04/19/2012 | WO2012051386A2 Reagent storage in an assay device |
| 04/19/2012 | WO2012051367A2 Carbon deposit simulation bench and methods therefor |
| 04/19/2012 | WO2012051301A1 Methods for identifying modulators of triglyceride metabolism, for modulating triglyceride metabolism and for identifying subjects at risk for abnormal triglyceride metabolism |
| 04/19/2012 | WO2012051290A2 Device for predicting gloss of low gloss coating by wet color measurement |
| 04/19/2012 | WO2012051282A2 Piwil2-like (pl2l) proteins-targeted cancer diagnosis and therapy |
| 04/19/2012 | WO2012051208A2 Identifying rearrangements in a sequenced genome |
| 04/19/2012 | WO2012051207A2 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsup90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS |
| 04/19/2012 | WO2012051206A1 System and method for cell analysis |
| 04/19/2012 | WO2012051205A2 Devices, systems and methods for the collection of body fluids |
| 04/19/2012 | WO2012051190A2 Fluid pressure-viscosity analyzer for downhole fluid sampling pressure drop rate setting |
| 04/19/2012 | WO2012051109A2 Fluid compositional analysis by combined gas chromatographic and direct flash methods |
| 04/19/2012 | WO2012050981A1 Device for high throughput investigations of cellular interactions |
| 04/19/2012 | WO2012050883A1 Engineered human endosialin-expressing rodents |
| 04/19/2012 | WO2012050873A2 Fin-fet biosensor with improved sensitivity and specificity |
| 04/19/2012 | WO2012050844A1 Determining the quantity of a taggant in a liquid sample |
| 04/19/2012 | WO2012050828A2 Serum markets for identification of cutaneous systemic sclerosis subjects |
| 04/19/2012 | WO2012050753A2 Methods and extraction units employing vapor draw compositional analysis |
| 04/19/2012 | WO2012050646A2 Biomimetic chemical sensors using nanoelectronic readout of olfactory receptors |
| 04/19/2012 | WO2012050645A2 Pathogen detection |
| 04/19/2012 | WO2012050627A2 Dopaminergic neurons derived from induced pluripotent stem cells and method of making same |
| 04/19/2012 | WO2012050558A1 Molecular fingerprinting to identify inbreeding and outbreeding depressions |
| 04/19/2012 | WO2012050513A1 Method for identifying a risk of cardiovascular disease by analysing oral microbiota |
| 04/19/2012 | WO2012050365A2 Biomarker for diagnosing glioblastoma or predicting prognosis of glioblastoma patients, and use thereof |
| 04/19/2012 | WO2012049874A1 Biomarker for diagnosis of fatty liver diseases, method for measuring same, computer program and storage medium |
| 04/19/2012 | WO2012049864A1 Method for providing data to diagnose depression |
| 04/19/2012 | WO2012049664A2 Auto-antigen biomarkers for lupus |
| 04/19/2012 | WO2012049620A1 Measurement of properties of sample of curing compositions under high pressure |
| 04/19/2012 | WO2012049560A1 Biomarker for valvular heart disease |
| 04/19/2012 | WO2012049486A1 Analyte detection method |
| 04/19/2012 | WO2012049465A1 Assay device |
| 04/19/2012 | WO2012049369A1 Marker for cells |
| 04/19/2012 | WO2012049329A1 Method for predicting tyrosine kinase inhibitor (tki) resistance in patients suffering from chronic myelogenous leukemia (cml) |
| 04/19/2012 | WO2012049285A1 A method for the quantitative glycosylation analysis of proteins |
| 04/19/2012 | WO2012049278A1 Therapies for improving pulmonary function |
| 04/19/2012 | WO2012049251A1 Method for coating nanoparticles |
| 04/19/2012 | WO2012049238A1 Power management for a handheld medical device |
| 04/19/2012 | WO2012049229A1 Estrogen receptor alpha polypeptide sequence, diagnostic and therapeutic applications thereof |
| 04/19/2012 | WO2012049192A1 Ipp complex as marker for erlotinib treatment |
| 04/19/2012 | WO2012049075A1 Magnetic nanoparticle detection across a membrane |
| 04/19/2012 | WO2012048612A1 Method and system for analysing solution colour |
| 04/19/2012 | WO2012048607A1 Method for detecting pca3 and psa genes, and diagnostic kit thereof |
| 04/19/2012 | WO2012048372A1 Assay for disease detection |
| 04/19/2012 | WO2012048359A1 Optical evanescent field sensor |
| 04/19/2012 | WO2012016070A3 Lymphedema associated genes and model |
| 04/19/2012 | WO2012015592A3 Method and device for reference point indentation without a reference probe |
| 04/19/2012 | WO2012012168A3 Apparatus, system, and method for increasing measurement accuracy in a particle imaging device using light distribution |
| 04/19/2012 | WO2012009382A3 Molecular indicators of bladder cancer prognosis and prediction of treatment response |
| 04/19/2012 | WO2012009206A3 Sequencing reactions with alkali metal cations for pulse width control |
| 04/19/2012 | WO2011163476A3 Colorimetric method and device for detecting analyte quantities in fluids and materials |
| 04/19/2012 | WO2011163370A3 Analysis of microneutralization assay using curve-fitting constraints |
| 04/19/2012 | WO2011162847A3 Stress-based sensor, method and applications |
| 04/19/2012 | WO2011161544A8 Biomarker for fatigue, and use thereof |
| 04/19/2012 | WO2011160071A3 Device for sorting, classifying, and assaying partition behavior of cell membrane biomolecules and methods based thereon |